Company Filing History:
Years Active: 2000
Title: Manfred Hans Phillip: Innovator in Pharmaceutical Compositions
Introduction
Manfred Hans Phillip is a notable inventor based in Scarsdale, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit trypsin-like enzymes. His work has implications for therapeutic methods aimed at inhibiting thrombin, a crucial factor in blood coagulation.
Latest Patents
Manfred holds a patent for "Inhibitors of trypsin-like enzymes - Pharmaceutical compositions comprising compounds of the formula: ##STR1## in which X.dbd.H or is an N-protecting group; Y is 1-10 .alpha.-amino acids; Q1 and Q2 taken together represent the residue of a diol; R is C.sub.1-4, alkyl; and the asymmetric carbon atom marked * may have the D- or L-configuration." This patent is particularly valuable in the development of new therapeutic methods.
Career Highlights
Manfred is associated with Trigen GmbH, where he continues to innovate and contribute to the pharmaceutical industry. His expertise in the field has led to advancements that benefit medical science and patient care.
Collaborations
Manfred has worked alongside Goran Karl Claeson, contributing to various projects and enhancing the scope of their research endeavors.
Conclusion
Manfred Hans Phillip's work in pharmaceutical compositions showcases his dedication to innovation in the medical field. His patent on inhibitors of trypsin-like enzymes highlights the importance of his contributions to therapeutic methods.